Worth reading
35Immaterial
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Neutral
Direction inferred from the company’s description.Scale
22500
SharesWording
Definitive
How definitive the wording is.Details of issuance or disposal
Issuance of stock acquisition rights as equity compensation stock options
Who receives how much
22,500 shares of the Company’s common stock (1,500 shares per stock acquisition right)
3 directors of the CompanyEquivalent to 22,500 shares (15 stock acquisition rights)
The lower thin line represents the existing number of shares to which these shares will be added.
The payment amount per stock acquisition right is the per-share option price calculated using the Black-Scholes model, multiplied by the number of shares granted, rounded up to the nearest yen.
Amount of funds to be raised
Total amount to be paid: Not disclosed; estimated net proceeds: Not disclosed
Total Stock-Based Compensation
Monetary compensation equivalent to the total payment amount for the stock acquisition rights. Amount: Not disclosed.
Terms of the stock acquisition rights
Exercise price
The initial exercise price is ¥1 per share. No adjustment provisions are stated.
Exercise period
From 3 June 2026 to 2 June 2056
Number of Stock Acquisition Rights
Total to be issued: 15. Number of outstanding unexercised rights: Not disclosed.
Reason for acquisition without consideration
If shareholder approval is obtained for a merger, company split, share exchange or share transfer, an amendment to the articles of incorporation imposing transfer restrictions on all shares, or an amendment to the articles of incorporation imposing transfer restrictions or an acquisition provision covering all shares of a class of shares subject to the amendment, or if a Board of Directors resolution is adopted where shareholder approval is not required, the Company may acquire the stock acquisition rights without consideration on a date separately determined by the Board of Directors.
Categories and Number of Persons Covered
3 directors of the Company; 15 stock acquisition rights (equivalent to 22,500 shares)
Payment date
2 June 2026
Basis for determining the amount to be paid
Calculated using the Black-Scholes model. The share price is the closing price of the Company’s common stock on the Tokyo Stock Exchange on 2 June 2026, the expected remaining term is 15 years, and volatility is based on the closing prices on each trading day from 3 June 2011 to 2 June 2026. No discount rate or premium rate is stated.
Procedures under the Corporate Code of Conduct
The issuance was resolved by the Board of Directors pursuant to Articles 236, 238 and 240 of the Companies Act. Whether an independent third-party opinion was obtained or shareholder approval was sought: Not disclosed.
| Item | Details |
|---|---|
| Type of issuance or disposal | Issuance of stock acquisition rights as equity compensation stock options |
| Number of shares to be issued or disposed of | 22,500 shares of the Company’s common stock (1,500 shares per stock acquisition right) |
| Issue price and disposal price | The payment amount per stock acquisition right is the per-share option price calculated using the Black-Scholes model, multiplied by the number of shares granted, rounded up to the nearest yen. |
| Amount of funds to be raised | Total amount to be paid: Not disclosed; estimated net proceeds: Not disclosed |
| Payment date | 2 June 2026 |
| Intended allottee | Name 3 directors of the Company / Number of Shares Equivalent to 22,500 shares (15 stock acquisition rights) |
| Basis for determining the amount to be paid | Calculated using the Black-Scholes model. The share price is the closing price of the Company’s common stock on the Tokyo Stock Exchange on 2 June 2026, the expected remaining term is 15 years, and volatility is based on the closing prices on each trading day from 3 June 2011 to 2 June 2026. No discount rate or premium rate is stated. |
| Exercise price | The initial exercise price is ¥1 per share. No adjustment provisions are stated. |
| Exercise period | From 3 June 2026 to 2 June 2056 |
| Number of Stock Acquisition Rights | Total to be issued: 15. Number of outstanding unexercised rights: Not disclosed. |
| Reason for acquisition without consideration | If shareholder approval is obtained for a merger, company split, share exchange or share transfer, an amendment to the articles of incorporation imposing transfer restrictions on all shares, or an amendment to the articles of incorporation imposing transfer restrictions or an acquisition provision covering all shares of a class of shares subject to the amendment, or if a Board of Directors resolution is adopted where shareholder approval is not required, the Company may acquire the stock acquisition rights without consideration on a date separately determined by the Board of Directors. |
| Categories and Number of Persons Covered | 3 directors of the Company; 15 stock acquisition rights (equivalent to 22,500 shares) |
| Total Stock-Based Compensation | Monetary compensation equivalent to the total payment amount for the stock acquisition rights. Amount: Not disclosed. |
| Procedures under the Corporate Code of Conduct | The issuance was resolved by the Board of Directors pursuant to Articles 236, 238 and 240 of the Companies Act. Whether an independent third-party opinion was obtained or shareholder approval was sought: Not disclosed. |
Items this document does not state (14)
Total issue valueEstimated issuance expensesSpecific use of fundsIntended allottee's holding policyDilution RateTotal number of issued sharesTransfer restriction periodConditions for lifting transfer restrictionsUnderwriter / lead underwriterOverallotmentStock Split RatioMost recent equity financingMajor shareholders after the offeringImpact on Business Performance
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The purpose is to further align directors’ compensation with the Company’s performance and shareholder interests.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.